BackFoghorn Therapeutics Overview
Foghorn Therapeutics Inc

Foghorn Therapeutics Target Price

Explore Foghorn Therapeutics's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.64

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-02-17Jefferies$1280.7% upsideOpen
2025-12-18BTIG$1165.7% upsideOpen
2025-12-03Stifel Nicolaus$1280.7% upsideOpen
2024-12-17H.C. WainwrightFoghorn Therapeutics to $$1395.8% upsideOpen
2024-09-24Morgan StanleyVikram Purohit$935.5% upsideOpen
2024-08-19Evercore ISIGavin Clark-Gartner$20201.2% upsideOpen
2023-01-05BMO Capital$20201.2% upsideOpen
2022-11-21Morgan Stanley$14110.8% upsideOpen
2022-08-23Morgan StanleyVikram Purohit$15125.9% upsideOpen

Foghorn Therapeutics (FHTX) FAQ

Stockcircle tracks target price for Foghorn Therapeutics (FHTX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Foghorn Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main FHTX overview so you can move from this figure to the surrounding analysis quickly.